These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26795874)

  • 101. Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson's disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial.
    Laurencin C; Timestit N; Marques A; Duchez DD; Giordana C; Meoni S; Huddlestone M; Danaila T; Anheim M; Klinger H; Vidal T; Fatisson M; Caire C; Nourredine M; Boulinguez P; Dhelens C; Ballanger B; Prange S; Bin S; Thobois S
    J Neurol; 2023 Oct; 270(10):4851-4859. PubMed ID: 37338615
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Association of oral frailty and gait characteristics in patients with cerebral small vessel disease.
    Xie HY; Chen JL; Xia CQ; Zhang N; Xia ZX; Zhao HY; Huang YH
    BMC Neurol; 2024 Sep; 24(1):336. PubMed ID: 39256704
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Safety and tolerability of adjunct non-invasive vagus nerve stimulation in people with parkinson's: a study protocol.
    Sigurdsson HP; Hunter H; Alcock L; Wilson R; Pienaar I; Want E; Baker MR; Taylor JP; Rochester L; Yarnall AJ
    BMC Neurol; 2023 Feb; 23(1):58. PubMed ID: 36737716
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Immediate Effects of Lower Limb Sensory Simulation Using Smart Socks to Stabilize Gait in People with Parkinson's Disease.
    Brodie MA; Pelicioni PH; Okubo Y; Chan DY; Carroll V; Toson B; Vigano D; Macagno M; Sternberg S; Schreier G; Lovell NH
    Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38083091
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Enhanced Parkinson's gait, reduced fall risk, and improved cognitive function through multimodal rehabilitation combined with rivastigmine treatment.
    Huang J; Liang M; Jiang D; Qin B; Zhang W
    Am J Transl Res; 2024; 16(6):2379-2388. PubMed ID: 39006262
    [TBL] [Abstract][Full Text] [Related]  

  • 106. The impact of rivastigmine on post-surgical delirium and cognitive impairment; a randomized clinical trial.
    Massoudi N; Mohit B; Fathi M; Nooraei N; Hannani KK; ArianNik M
    Int J Geriatr Psychiatry; 2023 Jul; 38(7):e5970. PubMed ID: 37485727
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Cannabidiol-enriched cannabis extraction product in Parkinson's disease: A randomized, double-blind, and placebo-controlled trial in Buriram Hospital.
    Kanjanarangsichai A; Mitarnun W; Mitarnun W; Pangwong W; Laoharattanahirun N; Kajornrith W; Junlaor P; Nonghan P; Witthayapirote W; Sangkarom G
    J Neurosci Rural Pract; 2022; 13(4):663-668. PubMed ID: 36743777
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Evaluating the Effects of Rivastigmine on Decision-Making in Patients with Mild Cognitive Impairment by Cambridge Neuropsychological Test Automated Battery (CANTAB); A Randomized, Double-Blind, Placebo-Controlled Trial.
    Sadeghi S; Mohammadian F; Tehrani-Doost M; Gholami K; Mohebbi N
    Iran J Pharm Res; 2023; 22(1):e138943. PubMed ID: 38444714
    [TBL] [Abstract][Full Text] [Related]  

  • 109. The effect of single and repeated doses of rivastigmine on gastric myoelectric activity in experimental pigs.
    Tsianou CC; Kvetina J; Radochova V; Kohoutova D; Rejchrt S; Valis M; Zdarova Karasova J; Tacheci I; Knoblochova V; Soukup O; Bures J
    PLoS One; 2023; 18(6):e0286386. PubMed ID: 37262057
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Spinal cord stimulation therapy for patients with Parkinson's disease and gait problems (STEP-PD): study protocol for an exploratory, double-blind, randomised, placebo-controlled feasibility trial.
    Hvingelby VS; Højholt Terkelsen M; Johnsen EL; Møller M; Danielsen EH; Henriksen T; Glud AN; Tai Y; Møller Andersen AS; Meier K; Borghammer P; Moro E; Sørensen JCH; Pavese N
    BMJ Neurol Open; 2022; 4(2):e000333. PubMed ID: 36101543
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Unexpected Findings During Double-blind Discontinuation of Acetylcholinesterase Inhibitor Medications.
    Moo LR; Martinez E; Padala K; Dunay MA; Scali RR; Chen S; Thielke SM
    Clin Ther; 2021 Jun; 43(6):942-952. PubMed ID: 34127273
    [TBL] [Abstract][Full Text] [Related]  

  • 112. The Potential for Effect of a Six-Week Training Program for Gait Aid Use in Older People with Dementia with Unsteadiness of Gait: A Pilot Study.
    Lee DA; Burton E; Meyer C; Haines TP; Hunter S; Dawes H; Suttanon P; Fullarton S; Connelly F; Stout JC; Hill KD
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836110
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias.
    Fallon SJ; Plant O; Tabi YA; Manohar SG; Husain M
    Brain Commun; 2023; 5(4):fcad207. PubMed ID: 37545547
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Real-time auditory feedback for improving gait and walking in people with Parkinson's disease: a pilot and feasibility trial.
    Mayo NE; Mate KKV; Fellows LK; Morais JA; Sharp M; Lafontaine AL; Hill ET; Dawes H; Sharkh AA
    Pilot Feasibility Stud; 2024 Aug; 10(1):115. PubMed ID: 39192343
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Video-Based Kinematic Analysis of Movement Quality in a Phase 3 Clinical Trial of Troriluzole in Adults with Spinocerebellar Ataxia: A Post Hoc Analysis.
    L'Italien GJ; Oikonomou EK; Khera R; Potashman MH; Beiner MW; Maclaine GDH; Schmahmann JD; Perlman S; Coric V
    Neurol Ther; 2024 Aug; 13(4):1287-1301. PubMed ID: 38814532
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Letter in Response to Oral and Transdermal Rivastigmine for the Treatment of Anticholinergic Delirium: A Case Report.
    Jenrette JE; Lebin JA
    J Emerg Med; 2024 Feb; 66(2):262-263. PubMed ID: 38432708
    [No Abstract]   [Full Text] [Related]  

  • 117. [Rivastigmine and Parkinson's disease without dementia : Impact on gait stability and frequency of falling].
    Amadori K
    Z Gerontol Geriatr; 2016 Oct; 49(7):662-663. PubMed ID: 27599816
    [No Abstract]   [Full Text] [Related]  

  • 118. GPi vs STN deep brain stimulation for Parkinson disease: Three-year follow-up.
    Odekerken VJ; Boel JA; Schmand BA; de Haan RJ; Figee M; van den Munckhof P; Schuurman PR; de Bie RM;
    Neurology; 2016 Feb; 86(8):755-61. PubMed ID: 26819458
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Acetylcholinesterase inhibitors and gait: a steadying hand?
    Moreau C; Devos D; Defebvre L
    Lancet Neurol; 2016 Mar; 15(3):232-3. PubMed ID: 26795875
    [No Abstract]   [Full Text] [Related]  

  • 120. Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial.
    Raftopoulos R; Hickman SJ; Toosy A; Sharrack B; Mallik S; Paling D; Altmann DR; Yiannakas MC; Malladi P; Sheridan R; Sarrigiannis PG; Hoggard N; Koltzenburg M; Gandini Wheeler-Kingshott CA; Schmierer K; Giovannoni G; Miller DH; Kapoor R
    Lancet Neurol; 2016 Mar; 15(3):259-69. PubMed ID: 26822749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.